BioCentury on BioBusiness,
Chiron's strategy in U.K. patent dispute
Monday, October 11, 1993
Chiron Corp. has won a court case that justifies the calculated risk it took in
planning the global protection of its hepatitis C patent estate.
A British court last week upheld the key portions of the company's HCV patent in a suit
brought in 1992 by CHIR and its joint diagnostic business partners, Ortho Diagnostic
Systems Inc. and Ortho Diagnostic Systems Ltd., against Organon Teknika Ltd. and Murex
Diagnostics Ltd. (MXX) alleging infringement of CHIR's U.K. patent. The suits were based
on Organon's importation and sale of HCV tests manufactured by United Biomedical Inc. and
similar tests manufactured and sold by MXX.
CHIR chose the U.K. court because it is widely perceived to be the most rigorous venue for
testing biotech patents. "A fair question would be why would we sue in the U.K. -
words displayed of
To read this article, you must be an Archives subscriber. Please choose one of the options below.
All contents Copyright © 1993-2016 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Whether you want an individual subscription or need a global group license, we have the products,
the experience and the customer support that biopharma executives, researchers, investors, service providers,
and industry stakeholders have trusted for nearly two decades.
Let our Subscriber Services team customize the best intelligence package available in the industry to meet your needs.
Free Trial Subscription 4 Weeks of Access
BioCentury's Weekly Business Intelligence Journal
Get a 4-week free trial subscription to BioCentury.
Get 4 Weeks Free
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]